Health Catalyst (HCAT) Revenue (2018 - 2026)

Health Catalyst (HCAT) has reported Revenue for 9 consecutive years, with $70.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue fell 12.68% year-over-year to $70.5 million; the trailing twelve-month figure through Jun 2026 stood at $292.2 million (down 7.54% YoY), and the FY2025 full-year result was $311.1 million, up 1.48% from the prior year.
• Revenue steadied at $70.5 million in Q2 2026 per HCAT's latest filing, from $70.8 million in the prior quarter.
• Across five years, Revenue topped out at $80.7 million in Q2 2025 and bottomed at $68.1 million in Q1 2022.
• Historically, Revenue has averaged $74.0 million across 5 years, with a median of $74.3 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Revenue advanced 21.92% in 2022, then decreased 12.68% in 2026.
• Over 5 years, Revenue stood at $69.2 million in 2022, then grew by 8.56% to $75.1 million in 2023, then climbed by 6.02% to $79.6 million in 2024, then declined by 6.19% to $74.7 million in 2025, then slipped by 5.61% to $70.5 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $70.5 million, $70.8 million, and $74.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.